Arcutis Biotherapeutics, Inc. - ARQT
About Gravity Analytica
Recent News
- 09.17.2025 - Arcutis To Present Multiple New ZORYVE® (roflumilast) Data Analyses at European Academy of Dermatology and Venereology Congress
- 09.17.2025 - Arcutis To Present Multiple New ZORYVE® (roflumilast) Data Analyses at European Academy of Dermatology and Venereology Congress
- 09.17.2025 - Arcutis To Present Multiple New ZORYVE® (roflumilast) Data Analyses at European Academy of Dermatology and Venereology Congress
- 09.16.2025 - Allure Magazine Honors Arcutis’ ZORYVE® (roflumilast) with Prestigious Best of Beauty Breakthrough Award
- 09.16.2025 - Allure Magazine Honors Arcutis’ ZORYVE® (roflumilast) with Prestigious Best of Beauty Breakthrough Award
- 09.16.2025 - Allure Magazine Honors Arcutis’ ZORYVE® (roflumilast) with Prestigious Best of Beauty Breakthrough Award
- 09.10.2025 - HC Wainwright 27th Annual Global Investment Conference
- 09.10.2025 - HC Wainwright 27th Annual Global Investment Conference
- 09.09.2025 - Morgan Stanley’s 23rd Annual Global Healthcare Conference
- 09.09.2025 - Morgan Stanley’s 23rd Annual Global Healthcare Conference
Recent Filings
- 09.10.2025 - 4 Statement of changes in beneficial ownership of securities
- 09.09.2025 - 144 Report of proposed sale of securities
- 09.08.2025 - 144 Report of proposed sale of securities
- 09.08.2025 - 4 Statement of changes in beneficial ownership of securities
- 09.04.2025 - 4 Statement of changes in beneficial ownership of securities
- 09.04.2025 - 144 Report of proposed sale of securities